As VYKAT XR has become more widely available, reports of adverse events have emerged, including edema (swelling), respiratory complications and cardiac complications. While these reports do not establish that VYKAT XR caused these outcomes, they highlight the importance of informed prescribing, appropriate patient selection and careful monitoring of individuals receiving the treatment.
The joint statement has been developed to help healthcare professionals, families, and caregivers understand the current information available and support informed conversations about the potential benefits and risks of VYKAT XR.
We are also sharing the VYKAT XR Parent FAQ by PWSA | USA, which provides information for families on topics including effectiveness, side effects, dosing and other commonly asked questions.